BB Biotech
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- -
- Established
- 1993-01-01
- Employees
- -
- Market Cap
- $2.5B
- Website
- http://www.bbbiotech.ch
Kepler Capital Sticks to Their Buy Rating for BB Biotech (0JYO)
Kepler Capital's Nicolas Pauillac maintains Buy rating on BB Biotech (0JYO) with a CHF66.00 price target. BB Biotech has a Moderate Buy consensus and a one-year high of CHF49.75, low of CHF35.45. The company invests in biotechnology firms with established products.
© Copyright 2025. All Rights Reserved by MedPath